← Leaderboards
Annie E Hiniker
University Of California, San Francisco
$4,041,512
Attributed
$4,041,512
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,041,512 · 3
By mechanism
R01$2,167,255 · 1
K08$1,146,748 · 1
P30$727,509 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Tamara N Alliston$9,755,404
- Shelley R Adler$4,059,627
- Frederick M Hecht$27,618,536
- Robert H Edwards$25,121,332
- Lawrence Yang Zhu$106,693
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsNerve DegenerationResponseNeuropathologyBrain TissuePathologyNeurodegenerative DisordersMutantNeurotoxicityPathway InteractionsMolecularMutationLeadPhosphotransferasesGenesNovel TherapeuticsGuanosine Triphosphate PhosphohydrolasesAutomobile DrivingNew Therapeutic TargetLrrk2 GeneAlzheimer&AposMediatingOverexpressionProteins
Grant awards (10)
Targeting Proteostatic Mechanisms to Inhibit LRRK2-Mediated Neurodegeneration and Neuropathology$738,480
R01 · FY2025 · NS · contact PI
Neuropathology Core$727,509
P30 · FY2025 · AG · contact PI
Targeting proteostatic mechanisms to inhibit LRRK2-mediated neurodegeneration and neuropathology$780,220
R01 · FY2024 · NS · contact PI
Targeting proteostatic mechanisms to inhibit LRRK2-mediated neurodegeneration and neuropathology$648,555
R01 · FY2023 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$190,458
K08 · FY2018 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$190,458
K08 · FY2018 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$191,458
K08 · FY2017 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$191,458
K08 · FY2016 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$191,458
K08 · FY2015 · NS · contact PI
Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease$191,458
K08 · FY2014 · NS · contact PI